Safe Orthopaedics Announces the Consolidation of Its Share Capital and the Renewal of Its Board of Directors Following the Shareholders General Assembly of November 26th, 2019

Nachrichtenquelle: Business Wire (engl.)
26.11.2019, 19:31  |  116   |   |   

Regulatory News:

Safe Orthopaedics (Paris:ALSAF) (FR0012452746 – ALSAF), a company specialized in the design and marketing of always new and sterile single-use implants and instruments improving the minimally invasive treatment of spinal fracture conditions, announces today that the Shareholders General Assembly of this day approved all of the resolutions submitted to the vote of the meeting, including the consolidation of its share capital by grouping 150 existing shares for 1 new share, and decided the renewal of the Board of Directors. In this context, the newly formed Board of Directors appointed Pierre Dumouchel, current Chief Executive Officer of Safe Orthopaedics, as Chairman of the Board of Directors and implemented the consolidation of the share capital.

The process of the consolidation of its Company's shares will take place in December 2019.

The renewal of the Board of Directors is made in the context of the implementation, by the management team of the company, of a clear industrial and commercial development strategy, in the context of the cost reduction of its central functions.

The new independent directors of the company have a strong professional expertise:

- Mr. Philippe CHÊNE, 60 years old, is leading the company Winncare since 2012, a french medium-sized company specialized in the manufacturing and distribution of medical devices relating to patient mobility. Mr. Philippe Chêne is a graduate of EM Lyon and has held various positions as financial controller, marketing manager, sales manager and division director within international companies such as American Hospital Supply, Medtronic and Baxter, in France as well as in Europe.
Philippe Chêne chairs the French National Union of Medical Technologies Industry (“SNITEM”).

- Mr. Philippe PETROU, 57 years old, has spent his entire career in the banking and financial industry as well as in Counsel. He holds a DESS of Statistical and Computing Techniques and an Executive MBA of HEC.

Following various general management positions within Odier Bungener Courvoisier Bank, he joined the executive management in 1999. In 2001, he was appointed Secretary General and CFO for ABN-AMRO Group in France, then member of the Executive Board of Neuflize Schlumberger Mallet in 2003.
In 2007, he joined ALPHA BANK and became director of a banking institution in eastern Europe.
Since 2010, he supports medium-sized companies and Startups in France and abroad. He is Senior Advisor of Grant Thornton Executive since 2013.

Seite 1 von 2
Safe Orthopaedics Aktie jetzt über den Testsieger (Finanztest 11/2020) handeln, ab 0 € auf Smartbroker.de



Diesen Artikel teilen

0 Kommentare

Schreibe Deinen Kommentar

Bitte melden Sie sich an, um zu kommentieren. Anmelden | Registrieren

 

Disclaimer

Safe Orthopaedics Announces the Consolidation of Its Share Capital and the Renewal of Its Board of Directors Following the Shareholders General Assembly of November 26th, 2019 Regulatory News: Safe Orthopaedics (Paris:ALSAF) (FR0012452746 – ALSAF), a company specialized in the design and marketing of always new and sterile single-use implants and instruments improving the minimally invasive treatment of spinal fracture …

Meistgelesene Nachrichten des Autors

Titel
Titel
Titel
Titel